![](https://www.drugtargetreview.com/wp-content/uploads/shutterstock_2241155819-scaled.jpg)
Assessing the risk of HCC with machine learning
A novel screening tool may increase the five-year survival rate of hepatocellular carcinoma patients to 90 percent. Researchers at the University Pittsburgh School of Medicine have developed a serum-fusion-gene machine-learning (ML) model. Due to its …